COMBINED APPROACH TO BROADLY PROTECTIVE AIDS VACCINES: CORE B

广泛保护性艾滋病疫苗的综合方法：核心 B

• 批准号: 8172758
• 负责人: Shiu-Lok Hu
• 金额: $ 46.53万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8172758
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Evaluation; Family suidae; Funding; Grant; Institution; Intravenous; Macaca; Modeling; Pathogenicity; Research; Research Personnel; Resources; Source; Tail; United States National Institutes of Health; Vaccines; in vivo; vaccine efficacy

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a part of a study done in coordination with the CaNPRC to compare the in vivo infectivity and pathogenicity of a standard stock of SHIV-SF162 P4 developed for the evaluation of vaccine efficacy in macaque models. In this study, we determined the infectivity of SHIV-SF162 P4 in pig-tailed macaques after intravenous inoculation.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这是与CaNPRC合作进行的一项研究的一部分，旨在比较为评价猕猴模型中疫苗有效性而开发的SHIV-SF 162 P4标准储备液的体内感染性和致病性。在这项研究中，我们确定了猪尾猕猴静脉接种后，SHIV-SF 162 P4的感染性。